In conclusion, intrinsic mPGES-1 uniquely functions as an inducer of collagen deposition and a modulator of cytotoxic T-cell exhaustion; and specific pharmacologic inhibition of mPGES-1 may hold therapeutic promise as a safer alternative to COX-2 inhibitors for improving immune checkpoint–based therapies in melanoma. Here, PTGES is linked to melanoma.